---
title: "Genetic Technologies Stays Non‑Trading as Restructuring Under DOCA Continues"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280939082.md"
description: "Genetic Technologies Stays Non‑Trading as Restructuring Under DOCA Continues"
datetime: "2026-03-30T01:52:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280939082.md)
  - [en](https://longbridge.com/en/news/280939082.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280939082.md)
---

# Genetic Technologies Stays Non‑Trading as Restructuring Under DOCA Continues

Genetic Technologies Stays Non‑Trading as Restructuring Under DOCA Continues

### Related Stocks

- [GENE.US](https://longbridge.com/en/quote/GENE.US.md)
- [GTG.AU](https://longbridge.com/en/quote/GTG.AU.md)

## Related News & Research

- [DPC: Record revenue, margin expansion, and strategic partnerships drive strong FY 2026 outlook](https://longbridge.com/en/news/295528397.md)
- [Handelsbanken Fonder AB Decreases Stock Position in Fastenal Company $FAST](https://longbridge.com/en/news/295643496.md)
- [What To Expect From Trimble’s (TRMB) Q2 Earnings](https://longbridge.com/en/news/295477501.md)
- [REG - Team PLC - Holding(s) in Company](https://longbridge.com/en/news/295504142.md)
- [Exelon (EXC) Could Be 8% Undervalued Following Second Quarter Earnings](https://longbridge.com/en/news/295332296.md)